ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 2"
Episode Synopsis
In this second episode on advancing precision oncology through patient access to biomarkers and testing, the discussion focuses on the benefits of integrating multi-omic data in precision oncology and how it can enhance treatment selection. Our experts discuss the importance of looking beyond genomics and considering other omics, such as immunomics and metabolomics, to gain a better understanding of the tumor and the patient's immune system and physiology.
In God we trust